Background: Postictal refractoriness, i.e., the inability to elicit a new epileptic seizure immediately after the first one, is present in mature animals. Immature rats did not exhibit this refractoriness, and it is replaced by postictal potentiation. In addition to the immediate postictal potentiation, there is a delayed potentiation present at both ages. These phenomena were studied using cortical epileptic afterdischarges as a model. Objective: We aimed to analyze participation of adenosine A1 receptors in postictal potentiation and depression. Methods: Adenosine A1 receptors were studied by means of Western blotting in the cerebral cortex with a focus on the age groups studied electrophysiologically. Stimulation and recording electrodes were implanted epidurally in 12- and 25-day-old rats. The first stimulation always induced conditioning epileptic afterdischarge (AD), and 1 min after its end, the stimulation was repeated to elicit the second, testing AD. Then, the drugs were administered and paired stimulations were repeated 10 min later. A selective agonist CCPA (0.5 and 1 mg/kg i.p.) and a selective antagonist DPCPX (0.1, 0.5 and 1 mg/kg i.p.) were used to examine the possible participation of adenosine A1 receptors. Results: Control younger animals exhibited potentiation of the testing AD and a moderate increase in both conditioning and testing ADs after an injection of saline. The A1 receptor agonist CCPA shortened both post-drug ADs, and neither potentiation was present. The administration of an antagonist DPCPX resulted in marked prolongation of the conditioning AD (delayed potentiation), and the second testing AD was shorter than the post-drug conditioning AD, i.e., there was no longer immediate potentiation of ADs. To eliminate effects of the solvent dimethylsulfoxide, we added experiments with DPCPX suspended with the help of Tween 80. The results were similar, only the prolongation of ADs was not as large, and the testing ADs were significantly depressed. The older control group exhibited a nearly complete suppression of the first testing AD. There was no significant change in the conditioning and testing ADs after CCPA (delayed potentiation was blocked). Both groups of DPCPX-treated rats (with DMSO or Tween) exhibited significant augmentation of delayed potentiation but no significant difference in the immediate depression. Adenosine A1 receptors were present in the cerebral cortex of both age groups, and their quantity was higher in 12- than in 25-day-old animals. Conclusions: An agonist of the A1 receptor CCPA suppressed both types of postictal potentiation in 12-day-old rats, whereas the A1 antagonist DPCPX suppressed immediate potentiation but markedly augmented the delayed one. Immediate postictal refractoriness in 25-day-old rats was only moderately (non-significantly) affected; meanwhile, the delayed potentiation was strongly augmented.

Department of Developmental Epileptology Institute of Physiology Czech Academy of Sciences 14200 Prague Czech Republic

Department of Neurology 2nd Faculty of Medicine Motol University Hospital Charles University 15006 Prague Czech Republic

National Institute of Mental Health 25067 Klecany Czech Republic

Zobrazit více v PubMed

Boison D. Adenosine as a modulator of brain activity. Drug News Perspect. 2007;20:607–611. doi: 10.1358/dnp.2007.20.10.1181353. PubMed DOI

Jacobson K.A. Introduction to adenosine receptors as therapeutic targets. Handb. Exp. Pharmacol. 2009;193:1–24. doi: 10.1007/978-3-540-89615-9_1. PubMed DOI PMC

Fredholm B., Chen J.F., Cunha R.A., Svenningsson P., Vaugeois J.M. Adenosine and brain function. Int. Rev. Neurobiol. 2005;63:191–270. doi: 10.1016/S0074-7742(05)63007-3. PubMed DOI

Sebastião A.M., Ribeiro J.A. Adenosine receptors and the central nervous system. Handb. Exp. Pharmacol. 2009;193:471–534. doi: 10.1007/978-3-540-89615-9_16. PubMed DOI

Ribeiro J.A., Sebastião A.M., de Mendonça A. Adenosine receptors in the nervous system: Pathophysiological implications. Prog. Neurobiol. 2002;68:377–392. doi: 10.1016/S0301-0082(02)00155-7. PubMed DOI

Dunwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 2001;24:31–55. doi: 10.1146/annurev.neuro.24.1.31. PubMed DOI

Guo M., Tianfu L. Adenosine dysfunction in epilepsy and associated comorbidities. Curr. Drug Targets. 2020;23:344–357. doi: 10.2174/1389450122666210928145258. PubMed DOI

Dragunow M. Purinergic mechanisms in epilepsy. Progr. Neurobiol. 1988;31:85–108. doi: 10.1016/0301-0082(88)90028-7. PubMed DOI

Boison D. Adenosine and seizure termination: Endogenous mechanisms. Epilepsy Curr. 2013;13:35–37. doi: 10.5698/1535-7511-13.1.35. PubMed DOI PMC

Mareš P. A1 not A2A adenosine receptors play a role in cortical epileptic afterdischarges in immature rats. J. Neural Transm. 2014;121:1329–1336. doi: 10.1007/s00702-014-1234-y. PubMed DOI

During M.J., Spencer D.D. Adenosine: A potential mediator of seizure arrest and postictal refractoriness. Ann. Neurol. 1992;32:618–624. doi: 10.1002/ana.410320504. PubMed DOI

Mareš P. Anticonvulsant action of 2-chloroadenosine against pentetrazol-induced seizures in immature rats is due to activation of A1 adenosine receptors. J. Neural Transm. 2010;117:1269–1277. doi: 10.1007/s00702-010-0465-9. PubMed DOI

Frenk H., Engel J., Jr., Ackermann R.F., Shavit Z., Liebeskind J.C. Endogenous opioids may mediate postictal behavioral depression in amygdaloid kindled rats. Brain Res. 1979;167:435–440. doi: 10.1016/0006-8993(79)90842-4. PubMed DOI

Caldecott-Hazard S., Engel J., Jr. Limbic postictal events: Anatomical substrates and opioid receptor involvement. Prog. Neuropsychopharmacol. Biol. Psychiat. 1987;11:389–418. doi: 10.1016/0278-5846(87)90014-5. PubMed DOI

Velíšek L., Mareš P. Differential effects of naloxone on postictal depression. Epilepsy Res. 1992;12:37–43. doi: 10.1016/0920-1211(92)90089-C. PubMed DOI

Avanzini G., de Curtis M., Marescaux C., Panzica F., Spreafico R., Vergnes M. The role of thalamic reticular nucleus in the generation of thalamo-cortical activities subserving spike and waves. J. Neural Transm. 1992;S35:85–95. doi: 10.1007/978-3-7091-9206-1_6. PubMed DOI

Zilles K., Wree A. Cortex: Areal and Laminar Structure. In: Paxinos G., editor. The Rat Nervous System. Academic Press; San Diego, CA, USA: 1995. pp. 649–685.

Mareš P. Participation of GABAB receptors in cortical postictal excitability in immature rat. Eur. J. Pharmacol. 2018;818:26–29. doi: 10.1016/j.ejphar.2017.10.022. PubMed DOI

Mareš P., Kubová H. GABA-B, not GABA-A receptors play a role in cortical postictal refractoriness. Neuropharmacology. 2015;88:99–102. doi: 10.1016/j.neuropharm.2014.09.007. PubMed DOI

Mareš P., Kubová H. Developmental patterns of postictal refractoriness and potentiation akin to cortical stimulation. Epilepsia. 2015;56:e10–e14. doi: 10.1111/epi.12870. PubMed DOI

Jensen F.E. The role of glutamate receptor maturation in perinatal seizures and brain injury. Int. J. Dev. Neurosci. 2001;20:339–347. doi: 10.1016/S0736-5748(02)00012-6. PubMed DOI

Mareš P., Haugvicová R., Kubová H. Unequal development of thresholds for various phenomena induced by cortical stimulation in rats. Epilepsy Res. 2002;49:35–43. doi: 10.1016/S0920-1211(02)00009-8. PubMed DOI

Steriade M., Jones E.G., McCornick D.A. Thalamus, Vol. I, Organization and Function. Elsevier; Amsterdam, The Netherlands: 1997.

Geiger J.D., LaBella F.S., Nagy J.I. Ontogenesis of adenosine receptors in the central nervous system of the rat. Brain Res. 1984;315:97–104. doi: 10.1016/0165-3806(84)90080-4. PubMed DOI

Marangos P.J., Patel J., Stivers J. Ontogeny of adenosine binding sites in rat forebrain and cerebellum. J. Neurochem. 1982;39:267–270. doi: 10.1111/j.1471-4159.1982.tb04732.x. PubMed DOI

Morgan P.F., Montgomery P., Marangos P.J. Ontogenetic profile of the adenosine uptake sites in rat forebrain. J. Neurochem. 1987;49:852–855. doi: 10.1111/j.1471-4159.1987.tb00972.x. PubMed DOI

Insel T.R., Miller L.P., Gelhard R.E. The ontogeny of excitatory amino acid receptors in rat forebrain—I. N-methyl-D-aspartate and quisqualate receptors. Neuroscience. 1990;35:31–43. doi: 10.1016/0306-4522(90)90117-M. PubMed DOI

Jeong H.-J., Jang I.S., Nabekura J., Akaike N. Adenosine A1 receptor-mediated presynaptic inhibition of GABAergic transmission in immature rat hippocampal CA1 neurons. J. Neurophysiol. 2003;89:1214–1222. doi: 10.1152/jn.00516.2002. PubMed DOI

Boison D. Adenosine kinase: Exploitation for therapeutic gain. Pharmacol. Rev. 2013;65:906–943. doi: 10.1124/pr.112.006361. PubMed DOI PMC

Deb P.K., Deka S., Borah P., Abed S.N., Klotz K.-N. Medicinal chemistry and therapeutic potential of agonists, antagonists, and allosteric modulators of A1 adenosine receptor: Current status and perspectives. Curr. Pharmaceut. Des. 2019;25:2697–2715. doi: 10.2174/1381612825666190716100509. PubMed DOI

Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265–275. doi: 10.1016/S0021-9258(19)52451-6. PubMed DOI

Peterson E.R. A Simplification of the Protein Assay Method of Lowry et al. Which is More Generally Applicable. Anal. Biochem. 1997;83:346–356. doi: 10.1016/0003-2697(77)90043-4. PubMed DOI

Colella A.D., Chegenii N., Tea M.N., Gibbins I.L., Williams K.A., Chataway T.K. Comparison of stain-free gels with traditional immunoblot loading control methodology. Anal. Biochem. 2012;430:108–110. doi: 10.1016/j.ab.2012.08.015. PubMed DOI

Gilda J., Gomes A.V. Stain-Free total protein staining is a superior loading control to β-actin for Western blots. Anal. Biochem. 2013;440:186–188. doi: 10.1016/j.ab.2013.05.027. PubMed DOI PMC

Boison D. Adenosine kinase, epilepsy and stroke: Mechanisms and therapies. Trends Pharmacol. Sci. 2006;27:652–658. doi: 10.1016/j.tips.2006.10.008. PubMed DOI

Swiader M.J., Kotrowski J., Luszczki J. Modulation of adenosinergic system and its application for the treatment of epilepsy. Pharmacol. Rep. 2014;66:335–342. doi: 10.1016/j.pharep.2013.10.005. PubMed DOI

Boison D., Rho J.M. Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies. Neuropharmacology. 2020;167:107741. doi: 10.1016/j.neuropharm.2019.107741. PubMed DOI PMC

Kiese K., Jablonski J., Boison D., Kobow K. Dynamic regulation of the adenosine kinase gene during early postnatal brain development and maturation. Front. Molecul. Neurosci. 2016;9:99. doi: 10.3389/fnmol.2016.00099. PubMed DOI PMC

Klaft Z.-J., Duerrwald L.M., Gerevich Z., Dulla C.G. The adenosine A1 receptor agonist WAG 994 suppresses acute kainic acid-induced status epilepticus in vivo. Neuropharmacology. 2020;176:108213. doi: 10.1016/j.neuropharm.2020.108213. PubMed DOI PMC